Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

INGN

Inogen (INGN)

Inogen Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:INGN
DataHoraFonteTítuloCódigoCompanhia
12/06/202418:00Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:INGNInogen Inc
07/06/202418:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INGNInogen Inc
07/06/202418:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INGNInogen Inc
03/06/202417:05Business WireInogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness RatioNASDAQ:INGNInogen Inc
31/05/202417:43Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:INGNInogen Inc
14/05/202419:55Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INGNInogen Inc
08/05/202417:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INGNInogen Inc
07/05/202417:05Business WireInogen Announces First Quarter 2024 Financial ResultsNASDAQ:INGNInogen Inc
10/04/202409:30Business WireInogen to Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:INGNInogen Inc
25/03/202409:30Business WireInogen To Present at 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:INGNInogen Inc
07/03/202418:00Business WireInogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INGNInogen Inc
06/03/202422:41Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INGNInogen Inc
27/02/202418:05Business WireInogen Announces Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:INGNInogen Inc
14/02/202410:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INGNInogen Inc
30/01/202418:00Business WireInogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024NASDAQ:INGNInogen Inc
24/01/202418:00Business WireInogen Names Michael Bourque as New Chief Financial OfficerNASDAQ:INGNInogen Inc
13/11/202310:30Business WireInogen Announces Leadership Change with the Appointment of Kevin Smith as President and CEONASDAQ:INGNInogen Inc
09/11/202316:30Business WireInogen to Present at Upcoming Investor Conferences in November 2023NASDAQ:INGNInogen Inc
07/11/202318:05Business WireInogen Announces Third Quarter 2023 Financial ResultsNASDAQ:INGNInogen Inc
10/10/202317:00Business WireInogen to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:INGNInogen Inc
18/09/202309:30Business WireInogen Completes Acquisition of Physio-AssistNASDAQ:INGNInogen Inc
07/09/202309:30Business WireInogen Announces CFO Transition PlanNASDAQ:INGNInogen Inc
08/08/202309:30Business WireInogen Recognized as a Finalist for Ragan's CSR & Diversity Awards ProgramNASDAQ:INGNInogen Inc
07/08/202317:01Business WireInogen Announces Second Quarter 2023 Financial ResultsNASDAQ:INGNInogen Inc
07/08/202309:30Business WireInogen Achieves Best In Class 8-Year Expected Service Life Portable Oxygen ConcentratorsNASDAQ:INGNInogen Inc
24/07/202310:50Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:INGNInogen Inc
13/07/202309:30Business WireInogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-AssistNASDAQ:INGNInogen Inc
07/06/202307:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INGNInogen Inc
06/06/202307:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INGNInogen Inc
05/06/202317:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INGNInogen Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:INGN